HomeHealth Sciences Journalvol. 9 no. 1 (2020)

A comparative dose-response study on the efficacy and safety of intrathecal morphine effectiveness in post-cesarean patients under spinal anesthesia at a tertiary hospital

Dianne Mary Cel L. Reyes | Glenn D. Mariñas | Olivia C. Flores

 

Abstract:

Introduction : Intrathecal morphine, commonly administered at doses of 100 to 200 mcg, is a popular choice for post-cesarean analgesia; however, a trade-off between opioid analgesia and side effects exists. This study was conducted to determine the lowest dose of intrathecal morphine that will provide adequate analgesia with the least side effects among post-cesarean patients. Methods : Sixty term parturients for cesarean delivery under spinal anesthesia were randomized into three treatment groups to receive 50, 100 or 150 mcg of intrathecal morphine with a standard multimodal pain regimen and intravenous tramadol as needed. Pain scores, demand for rescue analgesic, and incidence of adverse effects (nausea, vomiting, and pruritus) during the first 24 hours’ post-spinal anesthesia were recorded and compared between groups. Results : Pain scores and demand for rescue doses of tramadol were higher for the 50-mcg group as compared to the other groups. There was no significant difference in pain scores between the 100 and 150-mcg groups. No rescue dose of tramadol was necessary in the 100 and 150-mcg groups. No significant difference was seen in the incidence and severity of nausea and vomiting across treatment groups. The incidence and severity of pruritus were significantly higher in the 150-mcg group. No significant difference was noted in the incidence and severity of pruritus between the 50 and 100-mcg groups. Conclusion : A dose of 100 mcg of intrathecal morphine, in combination with a multimodal regimen, provides adequate analgesia with the least side effects.



References:

1. Suresh M, Shnider SM, Levinson G. Shnider and Levinson’s Anesthesia for Obstetrics. 5th ed. Philadelphia: Wolters Kluwer Health/Lippincott Williams & Wilkins Health; 2013.

2. Bromage PR, Camporesi EM, Durant PA, et al. Rostral spread of epidural morphine. Anesthesiology 1982; 56(6): 431–6.

3. Sutton CD, Carvalho B. Optimal pain management after cesarean delivery. Anesthesiol Clin 2017 Mar; 35(1): 107-24. doi: 10.1016/j.anclin.2016.09.010

4. McDonnell NJ, Keating ML, Muchatuta NA, et al. Analgesia after caesarean delivery. Anaesth Intens Care 2009; 37(4): 539–51.

5. Hirose M, Hara Y, Hosokawa T, Tanaka Y. The effect of postoperative analgesia with continuous epidural bupivacaine after cesarean section on the amount of breast feeding and infant weight gain. Anesth Analg 1996 Jun; 82(6): 1166-9.

6. Spigset O. Anaesthetic agents and excretion in breast milk. Acta Anaesthesiol Scand 1994; 38(2): 94–103.

7. Hale TW. Anesthetic medications in breastfeeding mothers. J Hum Lact 1999; 15(3): 185-94.

8. Feilberg VL, Rosenborg D, Broen Christensen C, Mogensen JV. Excretion of morphine in human breast milk. Acta Anaesthesiol Scand 1989 Jul; 33(5): 426-8. doi: 10.1111/j.1399-6576.1989.tb02938.x

9. Wong JY, Carvalho B, Riley ET. Intrathecal morphine 100 and 200 μg for post-cesarean delivery analgesia: A trade-off between analgesic efficacy and side effects. Int J Obstet Anesth 2013 Jan; 22(1): 36-41.

10. Palmer CM, Emerson S, Volgoropolous D, Alves D. Dose-response relationship of intrathecal morphine for postcesarean analgesia. Anesthesiology 1999 Feb; 90(2): 437-44.

11. Dahl JB, Jeppesen IS, Jørgensen H, Wetterslev J, Møiniche S. Intraoperative and postoperative analgesic efficacy and adverse effects of intrathecal opioids in patients undergoing cesarean section with spinal anesthesia: A qualitative and quantitative systematic review of randomized controlled trials. Anesthesiology 1999 Dec; 91(6): 1919-27

12. Berger JS, Gonzalez A, Hopkins A, et al. Dose-response of intrathecal morphine when administered with intravenous ketorolac for post-cesarean analgesia: A two-center, prospective, randomized, blinded trial. Int J Obstet Anesth 2016 Dec; 28: 3-11. doi: 10.1016/j.ijoa.2016.08.003

13. Yang T, Breen TW, Archer D, et al. Comparison of 0.25 mg and 0.1 mg intrathecal morphine for analgesia after cesarean section. Can J Anaesth 1999; 46(9): 856–60.

14. Sviggum HP, Arendt KW, Jacob AK, et al. Intrathecal hydromorphone and morphine for postcesarean delivery analgesia: Determination of the ED90 using a sequential allocation biased-coin method. Anesth Analg 2016 Sep; 123(3): 690-7.

15. Girgin NK, Gurbet A, Turker G, Aksu H, Gulhan N. Intrathecal morphine in anesthesia for cesarean delivery: Dose-response relationship for combinations of low- dose intrathecal morphine and spinal bupivacaine. J Clin Anesth 2008 May; 20(3): 180-5. doi: 10.1016/j. jclinane.2007.07.010

16. Abouleish E, Rawal N, Rashad MN. The addition of 0.2 mg subarachnoid morphine to hyperbaric bupivacaine for cesarean delivery: A prospective study of 856 cases. Reg Anesth 1991; 16(3): 137-40.

17. Ginosar Y, Mirikatani E, Drover DR, Cohen SE, Riley ET. ED50 and ED95 of intrathecal hyperbaric bupivacaine coadministered with opioids for cesarean delivery. Anesthesiology 2004 Mar; 100(3): 676-82.

18. Cousins MJ, Mather LE. Intrathecal and epidural administration of opioids. Anesthesiology 1984; 61(3):276-310.

19. Galanti G. Caring for Patients from Different Cultures. 2nd ed. Philadelphia: University of Pennsylvania Press; 1997.

20. Pan PH. Post cesarean delivery pain management: Multimodal approach. Int J Obstet Anesth 2006; 15(3): 185-8